| Herpes Zoster Ophthalmicus SIGNS AND SYMPTOMS
Herpes zoster ophthalmicus (HZO) typically presents with nondescript facial
pain, fever and general malaise. About four days after onset, a vesicular skin rash
appears along the distribution of the fifth cranial nerve, characteristically respecting
the vertical midline. The vesicles will discharge fluid and begin to scab over after about
one week. The pain is extreme during the inflammatory stage, and patients are tremendously
symptomatic.
Ocular involvement may include follicular conjunctivitis, epithelial
and/or interstitial keratitis, dendritic keratitis, uveitis, scleritis or episcleritis,
chorioretinitis, optic neuropathy, and even neurogenic motility disorders (especially
fourth cranial nerve palsy). If you see vesicles at the tip of the nose (known as
Hutchinsons Sign), there is a 75 percent likelihood of ocular sequelae.
PATHOPHYSIOLOGY
HZO occurs when the trigeminal ganglion is invaded by the herpes zoster
virus, a varicella-type virus which is usually referred to as chicken pox in
children or shingles in adults. The virus remains dormant in trigeminal nerve
cells, and can become reactivated years later by a reduction in the immune system.
Neuronal spread of the virus occurs along the ophthalmic (1st) and less
frequently the maxillary (2nd) division of the fifth cranial nerve. Vesicular eruptions
occur at the terminal points of sensory innervation, causing extreme pain. Nasociliary
involvement will most likely cause ocular inflammation, typically affecting the tissues of
the anterior segment. Contiguous spread of the virus may lead to the involvement of other
cranial nerves, resulting in optic neuropathy (cranial nerve II) or isolated cranial nerve
palsies (cranial nerve III, IV or VI).
MANAGEMENT
The systemic component of this disorder is best treated with oral
acyclovir, (Zovirax), 600 to 800mg five times a day for seven to 10 days, starting as soon
as the condition is diagnosed. Recently, famciclovir (Famvir) 500mg p.o. t.i.d. has been
shown to be as effective in treating herpes zoster ophthalmicus as acyclovir 800mg fives
times per day. Timing is crucial, however, to avoid post-herpetic neuralgia. To achieve
maximal benefit from oral anti-viral medications, you must start therapy within 72 hours
of vesicular eruption. Otherwise, the patient is at risk for developing post-herpetic
neuralgia and the beneficial effects of oral anti-viral therapy are lost. You may also
wish to prescribe oral steroids to alleviate pain and associated facial edema. If so, try
40 to 60mg of prednisone daily, tapered slowly over 10 days. To treat the skin lesions,
applying an antibiotic-steroid ointment, such as Pred-G, to the affected areas twice
daily, may help.
Ocular management depends on the severity and tissues involved. In most
cases which involve uveitis or keratitis, use cycloplegia (homatropine 5% t.id./q.i.d. or
scopolamine 0.25%) b.i.d./q.i.d. After ruling out herpes simplex, its also possible
to prescribe a topical steroid such as Vexol or Pred Forte q2-q.h. In any compromised eye,
prophylaxis with a broad-spectrum antibiotic is a good idea. Finally, palliative treatment
consisting simply of cool compresses, and oral analgesics in extreme cases, can be
comforting. Cimetidine 400mg p.o. b.i.d may provide some additional relief from the
neuralgia; why this works is not entirely understood.
CLINICAL PEARLS
- People over age 70 have a much greater chance of HZO infection. Also,
those who are immunocompromised due to lymphoma, AIDS, Lyme disease, etc. are at an
increased risk.
- Ocular involvement varies greatly and is often confusing in the early
stages.
- Take extreme care when differentiating this condition from herpes simplex
virus (HSV), particularly when there is corneal involvement. One key consideration is that
the dendritic keratitis which occurs in HZO is infiltrative, while the HSV dendrites are
ulcerative.
- Also keep in mind the possibility of more involved and complex ocular
sequelae (chorioretinitis, optic neuropathy, cranial nerve palsies, uveitic glaucoma), and
apply appropriate management strategies in these cases.
- Start oral anti-viral therapy within 72 hours of vesicular eruption to
possibly avoid post-herpetic neuralgia.
Other reports in this section
|